Size Matters for Adjuvants

Like

Share this post

Choose a social network to share with, or copy the shortened URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Seder NBT cover image

Source: Ethan Tyler, Division of Medical Arts, NIH.

Vaccine designs that elicit a robust immune response against a pathogen without causing unneeded inflammation are in high demand. To ‘tune’ vaccines and achieve this balance, the adjuvant and its mode of delivery are critical. In a paper by Robert Seder and colleagues, the authors explore the use of different types of polymers to deliver Toll-like receptor agonists, a type of powerful adjuvant, and find that polymer-adjuvants best suited for vaccine design are those that form particles. The paper also examines factors that influence why some polymers work better than others.

The above image relates to the Seder and colleagues paper, available now at this link.

Irene Jarchum

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Biotechnology
Life Sciences > Biological Sciences > Biotechnology